Members |
associationTargetComponent |
triamcinolone acetonide 0.1% + neomycin 0.25% + gramicidin 0.025% + nystatin 100 000 units/g ear ointment, 5 g |
Unknown Cell Type 2 |
triamcinolone acetonide 0.1% oromucosal paste |
Unknown Cell Type 2 |
triamcinolone acetonide 0.1% oromucosal paste, 5 g |
Unknown Cell Type 2 |
triamcinolone acetonide 1 mg / 1 g oromucosal paste (medicinal product unit of use) |
Unknown Cell Type 2 |
triamcinolone acetonide 1 mg / 1 g oromucosal paste, 5 g (medicinal product pack) |
Unknown Cell Type 2 |
triclosan 1% application, 40 mL tube |
triclosan 1% solution, 40 mL tube |
triclosan 1% application, 20 x 40 mL tubes |
triclosan 1% solution, 20 x 40 mL tubes |
triclosan 1% application, tube |
triclosan 1% solution, tube |
triglycerides long chain with glucose polymer oral liquid, 1 L bottle |
triglycerides long chain with glucose polymer oral liquid, 1 L carton |
triglycerides long chain with glucose polymer oral liquid, 18 x 250 mL cans |
triglycerides long chain with glucose polymer oral liquid, 18 x 250 mL cartons |
triglycerides long chain with glucose polymer oral liquid, 250 mL can |
triglycerides long chain with glucose polymer oral liquid, 250 mL carton |
triglycerides long chain with glucose polymer oral liquid, 6 x 1 L bottles |
triglycerides long chain with glucose polymer oral liquid, 6 x 1 L cartons |
triglycerides medium chain formula powder for oral liquid, 400 g |
protein formula with carbohydrate, fat, vitamins and minerals powder for oral liquid, 400 g |
typhoid fever polysaccharide vaccine |
Salmonella typhi inactivated antigen |
typhoid fever polysaccharide vaccine |
typhoid inactivated vaccine |
typhoid fever polysaccharide vaccine 25 microgram/0.5 mL injection, syringe |
typhoid inactivated vaccine injection, 0.5 mL syringe |
typhoid fever polysaccharide vaccine 25 microgram/0.5 mL injection, 0.5 mL syringe |
typhoid inactivated vaccine injection, 0.5 mL syringe |
typhoid fever polysaccharide vaccine 25 microgram/0.5 mL injection, 10 x 0.5 mL syringes |
typhoid inactivated vaccine injection, 10 x 0.5 mL syringes |
typhoid fever live attenuated oral vaccine |
Salmonella typhi live antigen |
typhoid fever live attenuated oral vaccine |
typhoid live vaccine |
typhoid fever live attenuated oral vaccine enteric capsule |
typhoid live vaccine enteric capsule |
typhoid fever live attenuated oral vaccine enteric capsule, 3 |
typhoid live vaccine enteric capsule, 3 |
uncoated tablet |
tablet |
vespula spp venom |
yellow jacket venom |
vespula spp venom |
yellow jacket venom |
vespula spp venom 550 microgram injection, vial |
yellow jacket venom 550 microgram injection, vial |
von Willebrand disease |
von Willebrand disorder |
zinc (as sulfate monohydrate) 50 mg capsule |
zinc 50 mg capsule |
zinc (as sulfate monohydrate) 50 mg capsule, 100 |
zinc 50 mg capsule, 100 |
zinc gluconate 228.5 mg tablet |
zinc 30 mg tablet |
zinc gluconate 228.5 mg tablet, 120 |
zinc 30 mg tablet, 120 |
zinc gluconate 228.5 mg tablet, 60 |
zinc 30 mg tablet, 60 |
zinc oxide 20.6% ointment, 3.5 g |
zinc oxide 20.6% ointment, 3.5 g sachet |
zinc oxide 25% + maize starch 55.85% + purified talc 18.07% + chlorphenesin 1% dusting powder |
Unknown Cell Type 2 |
zinc oxide 25% + maize starch 55.85% + purified talc 18.07% + chlorphenesin 1% dusting powder, 100 g |
Unknown Cell Type 2 |
zinc oxide 25% + maize starch 72.4% dusting powder |
Unknown Cell Type 2 |
zinc oxide 25% + maize starch 72.4% dusting powder, 150 g |
Unknown Cell Type 2 |
zinc oxide 25% + starch 25% + talc 50% dusting powder |
Unknown Cell Type 2 |
zinc oxide 25% + starch 25% + talc 50% dusting powder, 100 g |
Unknown Cell Type 2 |
zinc oxide 25% dusting powder |
Unknown Cell Type 2 |
zinc oxide 25% dusting powder, 100 g |
Unknown Cell Type 2 |
zinc oxide 250 mg / 1 g dusting powder (medicinal product unit of use) |
Unknown Cell Type 2 |
zinc oxide 250 mg / 1 g dusting powder, 100 g (medicinal product pack) |
Unknown Cell Type 2 |
zinc sulfate monohydrate |
zinc |